Literature DB >> 27498203

Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.

Molly K Barnhart1,2, Elizabeth C Ward3,4, Bena Cartmill4,5, Rachelle A Robinson6, Virginia A Simms6, Sophie J Chandler6, Elea T Wurth7, Robert I Smee8,9,10.   

Abstract

A proportion of patients with head and neck cancer (HNC) experience significant swallowing difficulty during and post-radiotherapy/chemoradiotherapy (RT/CRT). Identifying patients during the pretreatment period who are anticipated to have compromised oral intake would allow for early and accurate patient education, and prioritisation of their management. Ascertaining a clear set of pretreatment predictors from the literature is challenging due to heterogeneity in study designs and patient cohorts, with minimal prospective data available (especially at 1-month post-treatment). The objectives of this study were to investigate which pretreatment factors predicted compromised oral intake and feeding tube use at 1 and 6 months post-RT/CRT. Prospective data were collected on 80 consecutive HNC patients receiving RT/CRT from 2011 to 2014. The primary outcome was to identify predictors of a modified diet at 1 and 6 months post-RT/CRT. Secondary outcomes were to identify predictors of feeding tube use at these time intervals, and <6 vs. >6 week duration of feeding tube use. Multivariate analysis revealed bilateral neck radiotherapy treatment was a strong predictor of modified diets at 1 month (p < 0.001), and T-stages T3/T4 a predictor of modified diets at 6 months (p = 0.03). Patients treated with concurrent CRT (p = 0.02) and bilateral neck treatment (p = 0.02) predicted feeding tube use at 1 month, and concurrent CRT predicted feeding tube use for >6 weeks (p = 0.04). Therefore, patients receiving bilateral neck treatment and/or CRT are at greatest risk of requiring modified diets and feeding tube use early post-treatment, and should be prioritised for intervention and ongoing support.

Entities:  

Keywords:  Chemoradiotherapy; Dysphagia; Feeding tube; Oral intake; Predictors

Mesh:

Substances:

Year:  2016        PMID: 27498203     DOI: 10.1007/s00405-016-4241-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  34 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Gastrostomy tubes in patients with advanced head and neck cancer.

Authors:  Khwaja Asif Ahmed; Sandeep Samant; Francisco Vieira
Journal:  Laryngoscope       Date:  2005-01       Impact factor: 3.325

3.  Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Authors:  Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Dianna B Roberts; Jan S Lewin; Stephen Y Lai
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

4.  Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Authors:  Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Asher Lisec; Clare P Alvarez; Dianna B Roberts; Stephen Y Lai; Jan S Lewin
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

5.  Swallowing disorders in the first year after radiation and chemoradiation.

Authors:  Jeri A Logemann; Barbara Roa Pauloski; Alfred W Rademaker; Cathy L Lazarus; Joy Gaziano; Linda Stachowiak; Lisa Newman; Ellen MacCracken; Daphne Santa; Bharat Mittal
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

Review 6.  Dysphagia following chemoradiation for locally advanced head and neck cancer.

Authors:  N P Nguyen; C C Moltz; C Frank; P Vos; H J Smith; U Karlsson; S Dutta; F A Midyett; J Barloon; S Sallah
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

7.  Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.

Authors:  Klaudia U Hunter; Oliver E Lee; Teresa H Lyden; Marc J Haxer; Felix Y Feng; Mathew Schipper; Francis Worden; Mark E Prince; Scott A McLean; Gregory T Wolf; Carol R Bradford; Douglas B Chepeha; Avraham Eisbruch
Journal:  Head Neck       Date:  2013-06-01       Impact factor: 3.147

8.  Tonsillar cancer: the Peter MacCallum experience with unilateral and bilateral irradiation.

Authors:  Chen Liu; Gaelle Dutu; Lester J Peters; Danny Rischin; June Corry
Journal:  Head Neck       Date:  2013-06-01       Impact factor: 3.147

Review 9.  Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review.

Authors:  Shlomo A Koyfman; David J Adelstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-01       Impact factor: 7.038

10.  Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long?

Authors:  Hiroto Ishiki; Yusuke Onozawa; Takashi Kojima; Shuichi Hironaka; Akira Fukutomi; Hirofumi Yasui; Kentaro Yamazaki; Keisei Taku; Nozomu Machida; Narikazu Boku; Takayuki Hashimoto; Tetsuo Nishimura
Journal:  ISRN Oncol       Date:  2012-02-13
View more
  2 in total

1.  Nasogastric Feeding Tube/Dobhoff Placement: A Multidisciplinary Approach to the Management of Malnutrition During Radiation Therapy in Patients With Head and Neck Cancer.

Authors:  Alex Coke; Marissa Gilbert; Sue Hill; Farzan Siddiqui
Journal:  Cureus       Date:  2022-05-11

2.  Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.

Authors:  Anna Guillen-Sola; Neus Bofill Soler; Ester Marco; Oscar Pera-Cegarra; Palmira Foro
Journal:  Trials       Date:  2019-08-14       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.